Exodus Point Capital Management, LP Praxis Precision Medicines, Inc. Transaction History

Exodus Point Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$1.88 - $36.45 $41,076 - $796,396	-21,849 Reduced 34.03%	42,360 $101,000
Q3 2022 Nov 10, 2022	SELL	$2.5 - $37.95 $99,025 - $1.5 Million	-39,610 Reduced 38.15%	64,209 $146,000
Q2 2022 Aug 19, 2022	BUY	$1.75 - $11.34 $181,683 - $1.18 Million	103,819 New	103,819 $254,000

75K

Ticker PRAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,576,100
Market Cap $3.54B
Description
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.